02/15/2023
Daytona 500 Event Info: Date: Sunday, February 19 Time: 2:30 p.m. ET Event: 65th Daytona 500 Series: NASCAR Cup Series (NCS) Location: Daytona Beach, Florida Format: 200 laps, Stages: 65-65-70 TV: FOX Radio: MRN, SiriusXM NASCAR Radio Weekend Schedule: Wednesday: 8:15 p.m. ET, Qualifying (FS1, MRN, SiriusXM ...
02/06/2023
LOS ANGELES (Feb. 5, 2023) – The LA Coliseum played host to the NASCAR Cup Series’ exhibition, season-opening race for the second year in a row Sunday afternoon. Despite a strong effort, RFK’s Ford Mustangs did not qualify for the main, 150-lap event. RFK turns its focus to the official start ...
02/01/2023
Event Info: Date: Sunday, February 5 Time: 8 p.m. ET Event: Clash at The Coliseum Series: NASCAR Cup Series (NCS) Location: Los Angeles, California Format: 150 laps TV: FOX Radio: MRN, SiriusXM NASCAR Radio Weekend Schedule: Saturday: 3 p.m. ET, Practice (FS1) Saturday: 5:30 p.m. ET, Qualifying (FS1) Sunday: ...
01/30/2023
CONCORD, N.C. (Jan. 30, 2023) – RFK Racing has announced that King’s Hawaiian, the iconic bread company that joined the team in 2022, has returned in an expanded role and will serve as a primary partner for Brad Keselowski and the No. 6 team in multiple races in 2023 and beyond. “Our team ...
01/26/2023
CONCORD, N.C. (Jan. 26, 2023) – RFK Racing has announced that Solomon Plumbing, who joined the team in 2022, has expanded its partnership in 2023 and beyond. The Michigan-based company will serve as the primary for multiple races on NASCAR Champion Brad Keselowski’s No. 6 Ford this season, kicking ...
01/19/2023
CONCORD, N.C. (Jan. 19, 2023) – RFK Racing has announced that Castrol®, a partner of the team since 2019, has again expanded its partnership with the championship organization as part of a multi-year renewal. The iconic brand will continue to serve as the team’s official oil partner, while expanding ...
01/11/2023
CONCORD, N.C. (Jan. 11, 2023) – RFK Racing has announced that Esperion Therapeutics, a Michigan-based pharmaceutical company, has partnered with the team for a multi-year agreement pursuant to which Esperion will promote two cholesterol lowering treatments – NEXLIZET (bempedoic acid and ezetimibe) ...
